Technical Analysis for FGEN - FibroGen, Inc

Grade Last Price % Change Price Change
grade B 51.295 0.99% 0.51
FGEN closed up 0.24 percent on Thursday, January 17, 2019, on 1.16 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical FGEN trend table...

Date Alert Name Type % Chg
Jan 17 New Uptrend Bullish 0.99%
Jan 17 Doji - Bearish? Reversal 0.99%
Jan 17 Multiple of Ten Bullish Other 0.99%
Jan 17 Overbought Stochastic Strength 0.99%
Jan 17 Up 3 Days in a Row Strength 0.99%
Jan 17 Upper Bollinger Band Touch Strength 0.99%
Jan 16 Multiple of Ten Bullish Other 1.23%
Jan 16 Gapped Up Strength 1.23%
Jan 16 Overbought Stochastic Strength 1.23%
Jan 15 Overbought Stochastic Strength 4.45%

Older signals for FGEN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
FibroGen, Inc. operates as a research-based biopharmaceutical company in the United States. The company focuses on the discovery, development, and commercialization of therapeutic agents to treat serious unmet medical needs. The company develops roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019, a monoclonal antibody, which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. It also focuses on use of the proprietary type III recombinant human collagens in its biosynthetic corneal implant product candidate, FG-5200 for the treatment of corneal blindness. The company was incorporated in 1993 and is headquartered in San Francisco, California.
Is FGEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 68.55
52 Week Low 37.27
Average Volume 653,878
200-Day Moving Average 52.6548
50-Day Moving Average 42.7558
20-Day Moving Average 45.6765
10-Day Moving Average 48.185
Average True Range 2.3403
ADX 25.08
+DI 31.4974
-DI 14.3215
Chandelier Exit (Long, 3 ATRs ) 45.2391
Chandelier Exit (Short, 3 ATRs ) 45.3009
Upper Bollinger Band 51.8898
Lower Bollinger Band 39.4632
Percent B (%b) 0.91
BandWidth 27.205675
MACD Line 2.0436
MACD Signal Line 1.4916
MACD Histogram 0.552
Fundamentals Value
Market Cap 3.62 Billion
Num Shares 71.2 Million
EPS -1.92
Price-to-Earnings (P/E) Ratio -26.45
Price-to-Sales 32.73
Price-to-Book 16.72
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 54.77
Resistance 3 (R3) 54.81 53.54 54.10
Resistance 2 (R2) 53.54 52.52 53.51 53.88
Resistance 1 (R1) 52.16 51.90 52.85 52.12 53.66
Pivot Point 50.89 50.89 51.23 50.86 50.89
Support 1 (S1) 49.51 49.87 50.20 49.47 47.92
Support 2 (S2) 48.24 49.25 48.21 47.70
Support 3 (S3) 46.86 48.24 47.48
Support 4 (S4) 46.82